Thomas Lingelbach

Thomas Lingelbach currently works at Valneva SE, as President, Chief Executive Officer & Director from 2023, Intercell Austria AG, as President & Chief Executive Officer from 2013, Grätzelmixer GmbH, as Chief Executive Officer from 2017, Vaccines Holdings Sweden AB, as Chairman from 2014, Valneva Sweden AB, as Chairman from 2015, Valneva Scotland Ltd., as Director from 2006, VALNEVA Austria GmbH, as Co-Managing Director from 2013, Valneva UK Ltd., as Director from 2015, and Valneva Canada, Inc., as Director from 2015.
Dr. Lingelbach also formerly worked at Intercell AG, as President & Chief Executive Officer from 2011 to 2013, Valneva Usa, Inc. (United States), as President, Chief Executive Officer & Director, Elatos GmbH, as Chief Executive Officer from 2013 to 2015, GSK Vaccines GmbH, as Managing Director & General Manager, Chiron Behring Gmbh & Co. Kg, as Managing Director, and Chiron Corp., as VP-Vaccines Global Industrial Operations from 1997 to 2005.
Dr. Lingelbach received his graduate degree from Technische Hochschule Mittelhessen.